HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Vesnarinone

HCID 5663
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
81840-15-5
Standard SMILES
COc1ccc(C(=O)N2CCN(c3ccc4c(c3)CCC(=O)N4)CC2)cc1OC
InChIKey
ZVNYJIZDIRKMBF-UHFFFAOYSA-N
Molecular formula
C22H25N3O4
Average molar mass
395.5 g/mol
Monoisotopic mass
395.18450629

Overview

Arkin (TN) is an organic molecular entity.

Names & identifiers

Preferred name
Vesnarinone
IUPAC
6-[4-(3,4-dimethoxybenzoyl)piperazin-1-yl]-3,4-dihydro-1H-quinolin-2-one
English name
VESNARINONE
Molecular formula
C22H25N3O4
Molecular weight
395.45

Names & synonyms

vesnarinone81840-15-5OPC-8212Arkin-ZArkinVesnarinonaArkin ZVesnarinonumDRG-02105COW40EV8MDTXSID802314111-(3,4-Dimethoxybenzoyl)-4-(1,2,3,4-tetrahydro-2-oxo-6-quinolinyl)piperazine
Show more names
OPC 8212CS-21390PC-8212PiteranometozineVesnarinone(OPC8212)VESNARINONE USP/EP/BPOPC8212OPC 8212Vesnarinone, 10 mM in DMSO
pieranometazine6-(4-((3,4-dimethoxyphenyl)carbonyl)piperazin-1-yl)-1,2,3,4-tetrahydroquinolin-2-one6-{4-[(3,4-dimethoxyphenyl)carbonyl]piperazin-1-yl}-1,2,3,4-tetrahydroquinolin-2-oneRefChem:9018293,4-dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-piperazinyl)-2-1H-quinolinoneDTXCID801539023,4-Dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-pip-erazinyl)-2(1H)-quinolinonePiperazine, 1-(3,4-dimethoxybenzoyl)-4-(1,2,3,4-tetrahydr-o-2-oxo-6-quinolinyl)

Database identifiers

CAS
81840-15-5
PubChem CID
5663
DTXSID
DTXSID80231411
ChEMBL
CHEMBL17423
ChEBI
CHEBI:31237
UNII
5COW40EV8M
Nikkaji
J22.952K

Properties

Computed structural propertiesFilling in

XLogP
2.1
Topological polar surface area
71.1 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
5
Rotatable bonds
4
Heavy atoms
29
Formal charge
0
Complexity
593

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
Endocrine DisruptorsPotential endocrine disrupting compound

Physicochemical properties

Melting point
238.1 · 238.1-239.5° (Tominaga); mp 238.1-239.8° (Shimizu)
Boiling point
519.41 °C · 519.41°C (rough estimate)
Density
1.2414 · 1.2414 (rough estimate)
refractive index
1.65 · 1.6500 (estimate)
storage temp.
-20 °C · Store at -20°C
solubility
9.84 · DMSO:9.84(Max Conc. mg/mL);24.88(Max Conc. mM)DMSO:PBS (pH 7.2) (1:1):0.5(Max Conc. mg/mL);1.26(Max Conc. mM)DMF:3.0(Max Conc. mg/mL);7.59(Max Conc. mM)
form
A crystalline solid
pka
2.86 · 2.86(at 25℃)
color
White to off-white
FDA UNII
5 COW40EV8M · 5COW40EV8M
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P305+P351+P338

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P305+P351+P338

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 5 items

Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.

Substances that inhibit or prevent the proliferation of NEOPLASMS.

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).

Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases.

Cellular LocationsMembrane
Applications · 3 items

DescriptionVesnarinone is a new orally-active positive inotropic agent introduced for the treatment of congestive heart failure. It exerts a positive inotropic effect on the heart and has a peripheral vasodilatory effect. Vesnarinone is claimed not to affect heart rate or aggravate arrhythmia.

DescriptionVesnarinone is an inhibitor of phosphodiesterase 3 (PDE3; IC50s = 10.7 and 13.2 μM for PDE3A and PDE3B, respectively). It also inhibits ether-a-go-go-related gene 1 (ERG1) channels (IC50 = 1.1 μM in HEK293T cells expressing human ERG1). Vesnarinone (3-300 μM) increases contractile tension in isolated ventricular muscles of dog, cat, rabbit, and guinea pig in a dose-dependent manner. Oral and i.v. administration of vesnarinone increases right ventricular pressure with no effect on heart rate in dog models of tricuspid insufficiency- and pulmonary stenosis-induced congestive heart failure. It also increases contractility and coronary flow while decreasing heart rate in a guinea pig model of aortic stenosis-induced congestive heart failure. Formulations containing vesnarinone have been used for the treatment of congestive heart failure.

UsesCardiotonic.

Upstream & downstream products

Upstream raw materials

4-Methylanisole3,4-Dihydroquinolin-2(1H)-onePiperazineFormamide

Additional notes

DefinitionChEBI: Arkin (TN) is an organic molecular entity.

Related reactions

8 records
New reaction record
HRID 845743 reaction equation
HRID 845743As reactant
HRID 845744 reaction equation
HRID 845744As reactant
HRID 1649208 reaction equation
HRID 1649208As product
HRID 1649235 reaction equation
HRID 1649235As reactant
HRID 1649237 reaction equation
HRID 1649237As reactant
HRID 1649241 reaction equation
HRID 1649241As product
HRID 1649250 reaction equation
HRID 1649250As product
HRID 1649251 reaction equation
HRID 1649251As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes